Literature DB >> 15978232

Saw palmetto and finasteride in the treatment of category-III prostatitis/chronic pelvic pain syndrome.

Jennifer Yang1, Alexis E Te.   

Abstract

Chronic nonbacterial prostatitis/chronic pelvic pain syndrome is a common entity for which a standardized management has not been established. Patients often have a significant symptom complex and impact on quality of life, but very little is known about the efficacy of second- and third-line treatments, such as the use of herbal supplements. Many treatments studied in recent literature include antibiotics, alpha-blockade, anti-inflammatory agents, and cognitive behavioral interventions such as biofeedback and psychotherapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15978232     DOI: 10.1007/s11934-005-0026-1

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


  45 in total

1.  Effects of the lipidosterolic extract of Serenoa repens (Permixon) on human prostatic cell lines.

Authors:  L Ravenna; F Di Silverio; M A Russo; L Salvatori; E Morgante; S Morrone; M R Cardillo; A Russo; L Frati; A Gulino; E Petrangeli
Journal:  Prostate       Date:  1996-10       Impact factor: 4.104

2.  Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients.

Authors:  J C Carraro; J P Raynaud; G Koch; G D Chisholm; F Di Silverio; P Teillac; F C Da Silva; J Cauquil; D K Chopin; F C Hamdy; M Hanus; D Hauri; A Kalinteris; J Marencak; A Perier; P Perrin
Journal:  Prostate       Date:  1996-10       Impact factor: 4.104

3.  Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms.

Authors:  G S Gerber; D Kuznetsov; B C Johnson; J D Burstein
Journal:  Urology       Date:  2001-12       Impact factor: 2.649

Review 4.  Serenoa repens for benign prostatic hyperplasia.

Authors:  T Wilt; A Ishani; G Stark; R MacDonald; C Mulrow; J Lau
Journal:  Cochrane Database Syst Rev       Date:  2000

5.  Etiology of voiding dysfunction in men less than 50 years of age.

Authors:  S A Kaplan; E F Ikeguchi; R P Santarosa; P M D'Alisera; J Hendricks; A E Te; M I Miller
Journal:  Urology       Date:  1996-06       Impact factor: 2.649

Review 6.  Saw palmetto for the treatment of men with lower urinary tract symptoms.

Authors:  G S Gerber
Journal:  J Urol       Date:  2000-05       Impact factor: 7.450

7.  Evaluation of the bacterial flora of the prostate using a 16S rRNA gene based polymerase chain reaction.

Authors:  W W Hochreiter; J L Duncan; A J Schaeffer
Journal:  J Urol       Date:  2000-01       Impact factor: 7.450

8.  Results of treatment with pollen extract (Cernilton N) in chronic prostatitis and prostatodynia.

Authors:  E W Rugendorff; W Weidner; L Ebeling; A C Buck
Journal:  Br J Urol       Date:  1993-04

9.  A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome.

Authors:  Steven A Kaplan; Michael A Volpe; Alexis E Te
Journal:  J Urol       Date:  2004-01       Impact factor: 7.450

10.  Prostate biopsy culture findings of men with chronic pelvic pain syndrome do not differ from those of healthy controls.

Authors:  Jay C Lee; Charles H Muller; Ivan Rothman; Kathy J Agnew; David Eschenbach; Marcia A Ciol; Judith A Turner; Richard E Berger
Journal:  J Urol       Date:  2003-02       Impact factor: 7.450

View more
  1 in total

Review 1.  Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings.

Authors:  Susan Arentz; Jason Anthony Abbott; Caroline Anne Smith; Alan Bensoussan
Journal:  BMC Complement Altern Med       Date:  2014-12-18       Impact factor: 3.659

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.